0B68 Mason, Robert W - Thomas Jefferson University - Thomas Jefferson University

Robert W. Mason, PhD

Contact Dr. Mason


Most Recent Peer-reviewed Publications

  1. CD19-targeted nanodelivery of doxorubicin enhances therapeutic efficacy in B-cell acute lymphoblastic leukemia
  2. Loss of Sip1 leads to migration defects and retention of ectodermal markers duri 0B68 ng lens development
  3. Impact of enzyme replacement therapy and hematopoietic stem cell therapy on growth in patients with Hunter syndrome
  4. Novel heparan sulfate assay by using automated high-throughput mass spectrometry: Application to monitoring and screening for mucopolysaccharidoses
  5. Morquio A syndrome: Diagnosis and current and future therapies
  6. Newborn screening and diagnosis of mucopolysaccharidoses
  7. Dexamethasone-loaded block copolymer nanoparticles induce leukemia cell death and enhance therapeutic efficacy: A novel application in pediatric nanomedicine
  8. Inhibitors of cathepsins B and L induce autophagy and cell death in neuroblastoma cells
  9. Therapies of mucopolysaccharidosis IVA (Morquio A syndrome)
  10. Efficient differentiation of mouse embryonic stem cells into motor neurons
  11. Identification of the phosphorylation sites in the survival motor neuron protein by protein kinase A
  12. Proteomic assessment of a cell model of spinal muscular atrophy
  13. Induction of cell death in neuroblastoma by inhibition of cathepsins B and L
  14. Protein processing by the placental protease, cathepsin P
  15. Role of cathepsins in blastocyst hatching in the golden hamster
  16. Emerging Functions of Placental Cathepsins
  17. Development of a specific inhibitor for the placental protease, cathepsin P
  18. Expression of Cathepsin P mRNA, Protein and Activity in the Rat Choriocarcinoma Cell Line, Rcho-1, During Giant Cell Transformation
  19. Cathepsin L stabilizes the histone modification landscape on the Y chromosome and pericentromeric heterochromatin
  20. Defining the substrate specificity of mouse cathepsin P